Eike Gallmeier

3.4k total citations · 1 hit paper
61 papers, 2.6k citations indexed

About

Eike Gallmeier is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Eike Gallmeier has authored 61 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 33 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Eike Gallmeier's work include DNA Repair Mechanisms (17 papers), Pancreatic and Hepatic Oncology Research (14 papers) and CRISPR and Genetic Engineering (10 papers). Eike Gallmeier is often cited by papers focused on DNA Repair Mechanisms (17 papers), Pancreatic and Hepatic Oncology Research (14 papers) and CRISPR and Genetic Engineering (10 papers). Eike Gallmeier collaborates with scholars based in Germany, United States and Czechia. Eike Gallmeier's co-authors include Scott E. Kern, Jonathan R. Brody, Tomáš Hucl, Hartmut Wekerle, Wolfgang E. F. Klinkert, Ilse Bartke, Reinhard Hohlfeld, Martin Kerschensteiner, Christine Stadelmann and Edmund Hoppe and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Eike Gallmeier

59 papers receiving 2.5k citations

Hit Papers

Activated Human T Cells, B Cells, and Monocytes Produce B... 1999 2026 2008 2017 1999 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eike Gallmeier Germany 25 1.2k 958 466 416 382 61 2.6k
James R. Tonra United States 29 1.2k 1.0× 968 1.0× 320 0.7× 436 1.0× 198 0.5× 70 2.9k
Carmen Ruiz de Almodóvar Germany 30 1.7k 1.5× 504 0.5× 427 0.9× 583 1.4× 131 0.3× 55 3.3k
Tara Karnezis Australia 24 1.1k 1.0× 1.4k 1.5× 265 0.6× 296 0.7× 152 0.4× 35 2.6k
Anne Lewin United States 18 1.5k 1.2× 894 0.9× 601 1.3× 715 1.7× 95 0.2× 27 2.9k
Ilaria T. Cavarretta Italy 26 839 0.7× 527 0.6× 270 0.6× 490 1.2× 99 0.3× 49 2.2k
Jennifer Robertson Canada 21 1.4k 1.2× 490 0.5× 273 0.6× 555 1.3× 172 0.5× 32 2.9k
Christian Bernreuther Germany 34 1.4k 1.2× 336 0.4× 260 0.6× 654 1.6× 152 0.4× 75 3.3k
Tiziana Crepaldi Italy 28 1.5k 1.3× 416 0.4× 264 0.6× 205 0.5× 216 0.6× 70 2.9k
Paola Cavalla Italy 30 996 0.8× 468 0.5× 240 0.5× 328 0.8× 1.1k 2.9× 83 3.1k
Stefan Frentzel Switzerland 30 1.1k 1.0× 435 0.5× 305 0.7× 587 1.4× 104 0.3× 67 2.9k

Countries citing papers authored by Eike Gallmeier

Since Specialization
Citations

This map shows the geographic impact of Eike Gallmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eike Gallmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eike Gallmeier more than expected).

Fields of papers citing papers by Eike Gallmeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eike Gallmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eike Gallmeier. The network helps show where Eike Gallmeier may publish in the future.

Co-authorship network of co-authors of Eike Gallmeier

This figure shows the co-authorship network connecting the top 25 collaborators of Eike Gallmeier. A scholar is included among the top collaborators of Eike Gallmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eike Gallmeier. Eike Gallmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lankat–Buttgereit, Brigitte, et al.. (2024). Synthetic lethality between ATR and POLA1 reveals a potential new target for individualized cancer therapy. Neoplasia. 57. 101038–101038. 3 indexed citations
3.
Berger, Andreas W., Anke Reinacher‐Schick, Waldemar Uhl, et al.. (2019). A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer. Theranostics. 9(5). 1280–1287. 43 indexed citations
4.
Ettrich, Thomas J., Anke Reinacher‐Schick, Hana Algül, et al.. (2018). A composite liquid biomarker for non-invasive diagnosis of resectable pancreatic ductal adenocarcinoma. Annals of Oncology. 29. viii663–viii663.
5.
Krüger, Stephan, Michael Haas, Axel Kleespies, et al.. (2017). Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer – A retrospective cohort study. Thrombosis Research. 157. 9–15. 41 indexed citations
6.
Librizzi, Damiano, et al.. (2016). Intrapancreatic Accessory Spleen: A Differential Diagnosis to Neuroendocrine Tumors of the Pancreas on Ga-68-DOTATOC PET/CT. JOP, journal of the pancreas. 17(4). 1 indexed citations
7.
Büttner, Maike, Kerstin Amann, Raja Atreya, et al.. (2015). Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer. Gut. 65(7). 1139–1150. 56 indexed citations
8.
Ormanns, Steffen, Gerald Assmann, Simone Reu, et al.. (2014). ALK expression is absent in pancreatic ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 140(9). 1625–1628. 3 indexed citations
9.
10.
Gallmeier, Eike, Lydia Kriegl, Sabina Berezowska, et al.. (2013). Loss of TRAIL-Receptors Is a Recurrent Feature in Pancreatic Cancer and Determines the Prognosis of Patients with No Nodal Metastasis after Surgery. PLoS ONE. 8(2). e56760–e56760. 20 indexed citations
11.
Schäfer, Claus, Hendrik Seeliger, Gerald Assmann, et al.. (2011). Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. Journal of Cellular and Molecular Medicine. 16(8). 1776–1791. 38 indexed citations
12.
Neveling, Kornelia, Andreas Ziesch, Gerald Denk, et al.. (2010). Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents. Molecular Cancer. 9(1). 127–127. 22 indexed citations
13.
Boeck, Stefan, Klaus H. Metzeler, Andreas Hausmann, et al.. (2009). Cisplatin-Based Chemotherapy for Pulmonary Metastasized Germ Cell Tumors of the Testis – Be Aware of Acute Respiratory Distress Syndrome. Oncology Research and Treatment. 32(3). 125–128. 1 indexed citations
14.
Konishi, Hiroyuki, Bedri Karakas, Abde M. Abukhdeir, et al.. (2007). Knock-in of Mutant K- ras in Nontumorigenic Human Epithelial Cells as a New Model for Studying K- ras –Mediated Transformation. Cancer Research. 67(18). 8460–8467. 74 indexed citations
15.
Calhoun, Eric S., Tomáš Hucl, Eike Gallmeier, et al.. (2006). Identifying Allelic Loss and Homozygous Deletions in Pancreatic Cancer without Matched Normals Using High-Density Single-Nucleotide Polymorphism Arrays. Cancer Research. 66(16). 7920–7928. 66 indexed citations
16.
Cunningham, Steven C., Eike Gallmeier, Tomáš Hucl, et al.. (2006). Targeted Deletion of MKK4 in Cancer Cells: A Detrimental Phenotype Manifests as Decreased Experimental Metastasis and Suggests a Counterweight to the Evolution of Tumor-Suppressor Loss. Cancer Research. 66(11). 5560–5564. 39 indexed citations
17.
Brody, Jonathan R. & Eike Gallmeier. (2006). A proposed clinical test for monitoring fluoropyrimidine therapy: Detection and stability of thymidylate synthase ternary complexes. Cancer Biology & Therapy. 5(8). 923–927. 14 indexed citations
18.
Gallmeier, Eike & Scott E. Kern. (2005). Absence of specific cell killing of the BRCA2-deficient human cancer cell line CAPAN1 by poly(ADP-ribose) polymerase inhibition. Cancer Biology & Therapy. 4(7). 703–706. 48 indexed citations
19.
Gallmeier, Eike, et al.. (2005). Novel genotoxicity assays identify norethindrone to activate p53 and phosphorylate H2AX. Carcinogenesis. 26(10). 1811–1820. 23 indexed citations
20.
Heijden, Michiel S. van der, Jonathan R. Brody, Eike Gallmeier, et al.. (2004). Functional Defects in the Fanconi Anemia Pathway in Pancreatic Cancer Cells. American Journal Of Pathology. 165(2). 651–657. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026